Advertisement

Cytogenetics in Hematology

  • Olga Haus
  • Anna Poluha
  • Katarzyna Skonieczka
Chapter
Part of the Principles and Practice book series (PRINCIPLES)

Abstract

According to European LeukemiaNet—Workpackage Cytogenetics, cytogenetic analysis is mandatory to correctly diagnose and classify hematologic malignancies. Conventional cytogenetic analysis, which enables detection of both balanced and unbalanced chromosomal rearrangements, is still regarded as the gold standard of genetic diagnostics in hemato-oncology. However, a variety of rapidly developing state-of-the-art molecular and cyto-molecular techniques can now be applied, complementing the process of detection and analysis of recurrent genetic aberrations. Cytogenetics is currently recognized as an essential part of diagnostic process in hematologic malignancies. It helps to define specific disease entities, provides important prognostic and predictive information, influences therapy by setting the basis for individual treatment options that target cancer specific genetic abnormalities or their products, as well as helps to assess therapy effectiveness by indicating genetic remission or progression.

Keywords

Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Hematologic Malignancy Comparative Genomic Hybridization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The authors thank Ewa Duszeńko and Anna Jaśkowiec for their impressive cytogenetic work.

References

  1. Atlas Genet Cytogenet Oncol Haematol (2011) http://atlasgeneticsoncology.org. Accessed 10 Sept 2011
  2. Bacher U, Schnittger S, Haferlach T (2010) Molecular genetics in acute myeloid leukemia. Curr Opin Oncol 22:646–655PubMedCrossRefGoogle Scholar
  3. Breems DA, Van Putten WL, De Greef GE, Van Zelderen-Bhola SL, Gerssen-Schoorl KB, Mellink CH, Nieuwint A, Jotterand M, Hagemeijer A, Beverloo HB, Löwenberg B (2008) Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 26:4791–4797PubMedCrossRefGoogle Scholar
  4. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD, European LeukemiaNet (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453–474PubMedCrossRefGoogle Scholar
  5. Estey EH (2012) Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 87:90–99. doi: 10.1002/ajh.22246 CrossRefGoogle Scholar
  6. Fabarius A, Leitner A, Hochhaus A, Müller MC, Hanfstein B, Haferlach C, Göhring G, Schlegelberger B, Jotterand M, Reiter A, Jung-Munkwitz S, Proetel U, Schwaab J, Hofmann WK, Schubert J, Einsele H, Ho AD, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Baerlocher GM, Lauseker M, Pfirrmann M, Hasford J, Saussele S, Hehlmann R, Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group (2011) Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood 118:6760–6788PubMedCrossRefGoogle Scholar
  7. Fink SR, Belongie KJ, Paternoster SF, Smoley SA, Pardanani AD, Tefferi A, Van Dyke DL, Ketterling RP (2009) Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC deletion, FIP1L1/PDGFRA fusion and PDGFRA translocations. Leukemia Res 33:843–846CrossRefGoogle Scholar
  8. Foran JM (2010) New prognostic markers in acute myeloid leukemia: perspective from the clinic. Hematology Am Soc Hematol Educ Program 2010:47–55PubMedCrossRefGoogle Scholar
  9. Frohling S, Dohner H (2008) Chromosomal abnormalities in cancer. N Engl J Med 359:722–734PubMedCrossRefGoogle Scholar
  10. Gaidzik VI, Bullinger L, Schlenk RF, Zimmermann AS, Röck J, Paschka P, Corbacioglu A, Krauter J, Schlegelberger B, Ganser A, Späth D, Kündgen A, Schmidt-Wolf IG, Götze K, Nachbaur D, Pfreundschuh M, Horst HA, Döhner H, Döhner K (2011) RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. J Clin Oncol 29:1364–1372PubMedCrossRefGoogle Scholar
  11. Giagounidis A (2006) Improving treatment outcomes by understanding cytogenetics in myelodysplastic syndromes. Haematol Rep 2:5–10Google Scholar
  12. Gorczyca W (2008) Cytogenetics, FISH and molecular testing in hematologic malignancies. Informa Healthcare, UKGoogle Scholar
  13. Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, Wheatley K, Harrison CJ, Burnett AK, on behalf of the National Cancer Research Institute Adult Leukaemia Working Group (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116:354–365PubMedCrossRefGoogle Scholar
  14. Gulley ML, Shea TC, Fedoriw Y (2010) Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia. J Mol Diagn 12:3–16PubMedCrossRefGoogle Scholar
  15. Haferlach C, Rieder H, Lillington DM, Dastugue N, Hagemeijer A, Harbott J, Stilgenbauer S, Knuutila S, Johansson B, Fonatsch C (2007a) Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes. Genes Chromosomes Cancer 46:494–499PubMedCrossRefGoogle Scholar
  16. Haferlach T, Bacher U, Kern W, Schnittger S, Haferlach C (2007b) Diagnostic pathways in acute leukemias: a proposal for a multimodal approach. Ann Hematol 86:311–327PubMedCrossRefGoogle Scholar
  17. Harrison CJ, Haas O, Harbott J, Biondi A, Stanulla M, Trka J, Izraeli S, Biology and Diagnosis Committee of International Berlin-Frankfürt-Münster study group (2010) Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group. Brit J Haematol 151:132–142. doi: 10.1111/j.1365-2141.2010.08314.x CrossRefGoogle Scholar
  18. Hastings R, Howell R, Bricarelli FD, Kristoffersson U, Cavani S (2012) General guidelines and quality assurance for cytogenetics. A common European framework for quality assessment for constitutional, acquired and molecular cytogenetic investigations. E.C.A. permanent working group for cytogenetics and society. E.C.A—European Cytogeneticists Association Newsletter 29:7–25Google Scholar
  19. Huret JL (2008) Chromosomes, leukemias, solid tumors, hereditary cancers. Atlas Genet Cytogenet Oncol Haematol. Available via http://AtlasGeneticsOncology.org/Educ/Hempat_e.html. Accessed 29 Oct 2011
  20. Kotkowska A, Wawrzyniak E, Blonski JZ, Robak T, Korycka-Wolowiec A (2011) Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent. Leuk Res 35:1032–1038PubMedCrossRefGoogle Scholar
  21. Licht JD, Sternberg DW (2005) The molecular pathology of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2005:137–142CrossRefGoogle Scholar
  22. Marin D, Milojkovic D, Olavarria E, Khorashad JS, de Lavallade H, Reid AG, Foroni L, Rezvani K, Bua M, Dazzi F, Pavlu J, Klammer M, Kaeda JS, Goldman JM, Apperley JF (2008) European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor. Blood 112:4437–4444PubMedCrossRefGoogle Scholar
  23. Mrózek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD (2007) Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 109:431–448PubMedCrossRefGoogle Scholar
  24. Palandri F, Castagnetti F, Testoni N, Luatti S, Marzocchi G, Bassi S, Breccia M, Alimena G, Pungolino E, Rege-Cambrin G, Varaldo R, Miglino M, Specchia G, Zuffa E, Ferrara F, Bocchia M, Saglio G, Pane F, Alberti D, Martinelli G, Baccarani M, Rosti G, GIMEMA Working Party on Chronic Myeloid Leukemia (2008) Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6 year follow-up. Haematol 93:1792–1796CrossRefGoogle Scholar
  25. Patnaik MM, Hanson CA, Hodnefield JM, Knudson R, Van Dyke DL, Tefferi A (2011) Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia 25:266–270PubMedCrossRefGoogle Scholar
  26. Sandberg AA, Meloni-Ehrig AM (2010) Cytogenetics and genetics of human cancer: methods and accomplishments. Cancer Genet Cytogenet 203:102–126PubMedCrossRefGoogle Scholar
  27. Shaffer LG, Slovak ML, Campbell LJ (2009) An international system for human cytogenetic nomenclature ISCN 2009. Karger, BaselGoogle Scholar
  28. Soszynska K, Mucha B, Debski R, Skonieczka K, Duszenko E, Koltan A, Wysocki M, Haus O (2008) The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL. Ann Hematol 87:991–1002PubMedCrossRefGoogle Scholar
  29. Strefford JC, Worley H, Barber K, Wright S, Stewart AR, Robinson HM, Bettney G, van Delft FW, Atherton MG, Davies T, Griffiths M, Hing S, Ross FM, Talley P, Saha V, Moorman AV, Harrison CJ (2007) Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 26:4306–4318PubMedCrossRefGoogle Scholar
  30. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, LyonGoogle Scholar
  31. Szczepański T, Harrison CJ, van Dongen JJ (2010) Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol 11:880–889PubMedCrossRefGoogle Scholar
  32. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K, Langerak AW, van Dongen JJ (2004) Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 18:895–908PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Department of Clinical Genetics, Collegium Medicum in BydgoszczNicolaus Copernicus University in ToruńToruńPoland
  2. 2.Department of Hematology, Oncology, and Bone Marrow TransplantationMedical UniversityWrocławPoland
  3. 3.Department of Pediatric Hematology, Oncology and TransplantologyChildren’s University HospitalLublinPoland

Personalised recommendations